Identification of Prognostic Genes in Gliomas Based on Increased Microenvironment Stiffness

SIMPLE SUMMARY: Glioblastoma multiforme (GBM) is the most aggressive primary brain cancer; less than 50% of patients with GBM survive longer than 15 months. A biomarker for early GBM diagnosis can substantially increase the effectiveness of therapy for glioma patients. Increased stiffness of brain t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chaang-Ray, Chang, Rong-Shing, Chen, Chi-Shuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367320/
https://www.ncbi.nlm.nih.gov/pubmed/35954323
http://dx.doi.org/10.3390/cancers14153659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367320/
https://www.ncbi.nlm.nih.gov/pubmed/35954323
http://dx.doi.org/10.3390/cancers14153659

Ejemplares similares